The toll from cervical cancer is highest in lower-income countries, which often lack screening programs that can result in ...
A three-year campaign to bring vaccines against human papillomavirus (HPV) to low-income countries has prevented 1.4 million ...
Prophylactic HPV vaccines prevent infection but not existing disease. A nasal nanogel vaccine shows preclinical promise for ...
Dr. Erin Lovett, Schulich professor and OBGYN, spearheaded the development of a new Women’s Minor Procedure Room at LHSC that offers alternate pain management options to patients in a comfortable ...
Now, researchers from Chiba University, Japan, have developed a therapeutic HPV vaccine that can be administered through the ...
Cervical cancer, which affects the reproductive tract, is one of the most common cancers in women worldwide. It is primarily caused by human papillomavirus (HPV), a viral infection that spreads ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback